trial · primary record
P. vivax challenge agent derived from PvHMB-CCE001
Malaria
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 300 |
| Primary completion | 2027-11-26 |
| Primary endpoint | To assess the safety of the P. vivax IBSM model following inoculation of healthy participants. |
| Registry ID | NCT06607003 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:14.681Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06607003
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.